On May 1, 2025, Teladoc Health (TDOC, Financial), a leader in virtual healthcare services, saw its price target adjusted by Evercore ISI Group. The price target was lowered from $8.00 to $7.00 USD, marking a 12.50% decrease.
The adjustment was made by analyst Elizabeth Anderson. Despite the reduction in the price target, the current rating remains "In-Line", unchanged from the previous rating.
Teladoc Health (TDOC, Financial) continues to receive significant attention from investors and analysts as a major player in the healthcare industry, particularly in the telemedicine sector.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 19 analysts, the average target price for Teladoc Health Inc (TDOC, Financial) is $9.51 with a high estimate of $12.00 and a low estimate of $7.00. The average target implies an upside of 42.73% from the current price of $6.67. More detailed estimate data can be found on the Teladoc Health Inc (TDOC) Forecast page.
Based on the consensus recommendation from 26 brokerage firms, Teladoc Health Inc's (TDOC, Financial) average brokerage recommendation is currently 2.8, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Teladoc Health Inc (TDOC, Financial) in one year is $21.73, suggesting a upside of 226.03% from the current price of $6.665. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Teladoc Health Inc (TDOC) Summary page.
